Psyence Biomedical Income Statement (2023-2025) | PBM

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2023	Mar2024	Sep2024	Mar2025	Sep2025
Revenue & cost
Cost of Revenue (Quarter)			0.27M		0.05M
Operating items
Research & Development (Quarter)			0.27M		0.36M
Selling, General & Administrative (Quarter)			0.24M		0.22M
Operating Expenses (Quarter)			0.51M		0.57M
EBIT (Quarter)	-3.23M		1.16M		-1.51M
Non-operating items
Interest & Investment Income (Quarter)					0.07M
Other Non Operating Income (Quarter)			0.00M		257.00
Net income details
EBT (Quarter)	-3.23M		1.16M		-1.50M
Profit After Tax (Quarter)	-3.21M		0.14M		-0.75M
Income from Continuing Operations (Quarter)	-3.23M		1.16M		-1.50M
Consolidated Net Income (Quarter)	-3.23M		1.16M		-1.50M
Income towards Parent Company (Quarter)	-3.23M		1.16M		-1.50M
Net Income towards Common Stockholders (Quarter)	-3.23M		1.16M		-1.50M
Additional items
EPS (Basic) (Quarter)	-65.43		0.02		0.00
EPS (Weighted Average and Diluted) (Quarter)	-65.43		0.03		0.00
Shares Outstanding (Weighted Average) (Quarter)	0.05M	10.90M	52.94M	61.75M	1,481.53M
Shares Outstanding (Diluted Average) (Quarter)	0.05M	0.59M	34.73M		1,481.53M
EBITDA (Quarter)	-3.23M		0.04M		-0.75M
Interest Expenses (Quarter)			0.00M		-0.00M